IntelliSep

PCR-based diagnostic test for rapid sepsis detection, delivering results in under 2 hours with ultrasensitive pathogen identification. Designed for clinical microbiology and diagnostic laboratories to enable faster treatment decisions in sepsis cases.

Patented technology delivering antibiotic susceptibility testing results in hours instead of days, enabling timely sepsis treatment intervention.

An in vitro cellular immunoassay for rapid sepsis detection that identifies immune activity biomarkers within one hour of bloodstream infection. The assay detects LPS-induced TNF-alpha release to assess immunosuppression caused by bacteremia, enabling early clinical intervention and improved patient outcomes.

Rapid antibiotic susceptibility testing diagnostic system delivering results in hours instead of days for sepsis patients. Enables timely clinical intervention and appropriate antimicrobial selection.

A rapid molecular diagnostic test for sepsis diagnosis completed in approximately 20 minutes. This test helps identify causative pathogens and antimicrobial resistance directly from blood samples to support rapid clinical therapy decisions and improve patient survival chances in sepsis and septic shock.

Rapid diagnostic panel for identifying sepsis-causing pathogens and antimicrobial susceptibility at the bedside. Uses molecular and phenotypic analysis to enable fast, personalized antibiotic selection for critically ill patients. Delivers results within hours rather than days, supporting timely clinical decision-making in sepsis management.

Digital PCR-based test kit for rapid detection of pathogens and antibiotic resistance genes associated with sepsis. Provides comprehensive pathogen identification from blood samples within 2-3 hours.

High-sensitivity biomarker assay for early identification of sepsis in critically ill patients.

Procalcitonin test kit using fluorescence immunochromatography for rapid detection of bacterial infections and sepsis risk assessment. This point-of-care diagnostic enables quick patient stratification in clinical settings with results available within minutes, supporting early intervention in acute care environments.

Biomarker test for sepsis risk assessment that detects elevation earlier than CRP and PCT markers. Enables earlier clinical intervention in sepsis management.

An immunodiagnostic system for detecting respiratory tract infections, pneumonia, and sepsis through rapid detection with options for single or combined testing and quantitative analysis. Approved for market launch in December 2022, this system supports early diagnosis and treatment of bacterial infections and neonatal sepsis.

AP10 is a digital PCR-based assay for rapid detection of sepsis and bloodstream infections in clinical samples. The test kit enables pathogenic microorganism identification through molecular diagnostics, supporting early clinical decision-making in acute care settings. Designed for high-throughput laboratory use in hospital microbiology departments.